The information provided in this report is taken from www.sec.gov and many other data providers. While we have conducted our best efforts to ensure that the parsed data is accurate, we cannot guarantee its accuracy. Please use caution and understand that any consequences of its use are your own responsibility.
REGENXBIO Inc(NASDAQ:RGNX) 
REGENXBIO Inc., a clinical-stage biotechnology company, provides gene therapy product candidates to deliver genes to cells to address genetic defects or to enable cells in the body to produce therapeutic proteins or antibodies that are intended to impact disease. Its gene therapy product candidates ...
Website: http://www.regenxbio.com
Founded: 2008
Full Time Employees: 257
Sector: Healthcare
Industry: Biotechnology
REGENXBIO Days Payable Outstanding ttm (DPO)
REGENXBIO Days Receivable Outstanding ttm (DSO)
REGENXBIO Days Inventory Outstanding ttm (DIO)
REGENXBIO Op Cashflow Per Share ttm
REGENXBIO Free Cashflow Per Share ttm
REGENXBIO Cash Per Share ttm
REGENXBIO P/S ratio ttm
REGENXBIO (GAAP) P/E ratio ttm
REGENXBIO P/B ratio ttm
No extra charts and metrics for this ticker.